Bluebird bio

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$10,612
$16,101
$18,573
$7,834
Gross Profit
-1,169
-12,845
-7,291
-1,798
EBITDA
-39,744
-59,393
EBIT
-55,088
-75,919
Net Income
-60,808
-81,393
-69,804
-88,514
Net Change In Cash
10,612
16,101
18,573
7,834
Free Cash Flow
-69,208
-66,311
-76,451
-19,051
Cash
70,651
144,067
212,047
221,755
Basic Shares
193,893
193,716
193,583
192,772

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue
$29,497
$3,597
$3,662
$250,734
Gross Profit
-4,030
-6,480
-35,195
245,338
EBITDA
-215,559
-556,926
-553,633
EBIT
-220,560
-562,380
-559,259
Net Income
-211,913
-266,578
-562,638
-618,695
Net Change In Cash
29,497
3,597
3,662
250,734
Cost of Revenue
-167,036
-7,981
Free Cash Flow
-244,103
-366,161
-658,642
-499,337
Cash
221,755
113,006
161,160
317,705
Basic Shares
192,772
78,585
68,910
62,178

Earnings Calls

Quarter EPS
2024-09-30
-$0.31
2024-06-30
-$0.42
2024-03-31
-$0.36
2023-12-31
-$0.78